Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
SHR0302 placebo
DRUG
2 trials
Sponsors
Jiangsu HengRui Medicine Co., Ltd.
Conditions
Ankylosing Spondylitis
Non-radiographic Axial Spondyloarthritis
Phase 2
A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Ankylosing Spondylitis
Completed
NCT04481139
Jiangsu HengRui Medicine Co., Ltd.
Ankylosing Spondylitis
Start: 2020-10-14
End: 2023-05-12
Updated: 2023-07-27
Phase 3
A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Non-Radiographic Axial Spondyloarthritis
NCT05324631
Jiangsu HengRui Medicine Co., Ltd.
Non-radiographic Axial Spondyloarthritis
Start: 2022-08-16
End: 2024-12-11
Target: 300
Updated: 2022-09-02
Related Papers
Ivarmacitinib in patients with active ankylosing spondylitis: subgroup analysis based on key baseline features from a phase II/III trial.
2026-07-28
Ivarmacitinib improves patient-reported outcomes across multiple domains in patients with active ankylosing spondylitis: a <i>post hoc</i> analysis of a phase II/III trial.
2025-11-20